Diabetic Macular Edema Epidemiology Report 2022: Analysis and Forecasts, 2021-2031 - Focus on US, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com

The "Diabetic Macular Edema Epidemiology Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for DME in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

The report includes a 10-year epidemiology forecast for the diagnosed prevalent cases of DME. The diagnosed prevalent cases of DME are further segmented by age (20 years and older), sex, involvement of the eye (center-involving DME and non-center-involving DME) and by type of DME (focal-pattern DME and diffuse-pattern DME).

The following data describes epidemiology of DME. In the 7MM, the publisher's epidemiologists forecast an increase in the diagnosed prevalent cases of DME from 1,744,395 cases in 2021 to 2,031,337 cases in 2031, with an AGR of 1.64% during the forecast period.

Men accounted for more diagnosed prevalent cases of DME than women in the 7MM and it predominantly affects older adults. These findings are reflected in the publisher's forecast for the diagnosed prevalent cases for the 7MM.

Scope

• The Diabetic Macular Edema (DME) Epidemiology Report provides an overview of the risk factors and global trends of DME in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of DME. The diagnosed prevalent cases of DME are further segmented by age (20 years and older), sex, and involvement of the eye (center-involving DME and non-center-involving DME) and by type of DME (focal-pattern DME and diffuse-pattern DME). The model associated with the report also provides the diagnosed prevalent cases of clinically significant DME among the diagnosed DME population.
• The DME epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Buy

• Develop business strategies by understanding the trends shaping and driving the global DME market.
• Quantify patient populations in the global DME market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DME therapeutics in each of the markets covered.
• Understand magnitude of DME population by involvement of the eye and DME pattern.

Key Topics Covered:

1 Diabetic Macular Edema: Executive Summary

1.1 Catalyst

1.2 Related reports

1.3 Upcoming reports

2 Epidemiology

2.1 Disease background

2.2 Risk factors and comorbidities

2.3 Global and historical trends

2.4 7MM forecast methodology

2.4.1 Sources

2.4.2 Forecast assumptions and methods

2.4.3 Diagnosed prevalent cases of DME among the diagnosed DR population

2.4.4 Diagnosed prevalent cases of DME by involvement of the eye

2.4.5 Diagnosed prevalent cases of DME by type

2.5 Epidemiological forecast for DME (2021-31)

2.5.1 Diagnosed prevalent cases of DME among the diagnosed DR population

2.5.2 Age-specific diagnosed prevalent cases of DME among the diagnosed DR population

2.5.3 Sex-specific diagnosed prevalent cases of DME among the diagnosed DR population

2.5.4 Diagnosed prevalent cases of DME by involvement of the eye

2.5.5 Diagnosed prevalent cases of DME by type

2.6 Discussion

2.6.1 Epidemiological forecast insight

2.6.2 COVID-19 impact

2.6.3 Limitations of the analysis

2.6.4 Strengths of the analysis

3 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/cekldv

View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005833/en/